MyndTec Announces Partnership with SDVOSB Maness Veteran Medical to Distribute MyndMove™ to the US Department of Defense and The Department of Veterans Affairs
Originally Published: Jun 2, 2020 MISSISSAUGA, ON, June 2, 2020 /PRNewswire/ - To improve access for US veterans and active duty military to the latest innovative technology, MyndTec, an award-winning Canadian medical technology company announced today their partnership with Maness Veteran Medical (MVM), a proud Service-Disabled Veteran-Owned Small Business (SDVOSB), to distribute the MyndMove™ Device to the US Department of Defense (DoD) and Veterans Affairs (VA). MyndMove™ therapy is a revolutionary advancement approved in the US for use in the treatment of arm and hand paralysis caused by stroke or spinal cord injury (SCI). Nearly 5.4 million Americans live with paralysis, with stroke being the leading cause at 33.7% followed by SCI at 27.3%. The loss of independence as a result of paralysis is accompanied by the need for long term assistive care and subsequently, significant increases in healthcare costs. With the number continuing to grow each year, MyndTec is focused on enhancing treatment strategies with the use of MyndMove™ therapy to regain voluntary movement leading to greater independence. MVM's CEO, Johnathan Maness states, "MVM is focused on supplying the United States' VA and DoD hospitals…